the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Melaka launches 10-week measles-rubella immunisation drive from Aug 4

MELAKA: The Melaka government will conduct a 10-week Measles-Rubella Supplementary Immunisation Activity starting Aug 4 to address the increasing number of measles cases in the state.

State Health, Human Resources and Unity Committee chairman Datuk Ngwe Hee Sem said the free vaccination drive targets babies and children aged six to 59 months, born between Aug 1, 2020, and Jan 31, 2025, regardless of nationality. The campaign aims to cover over 46,000 children.

Vaccines will be available at health clinics, rural clinics, and Malaysian Armed Forces health centres via walk-ins, appointments, or the MySejahtera app. Outreach programmes will also be held at selected locations.

Ngwe noted that Melaka recorded 38 measles cases this year, with an incidence rate of 36.3 per million population between the first and 30th epidemiological week. This is lower than the 74 cases reported in 2024 but still exceeds the World Health Organisation’s elimination target of fewer than one case per million population.

He attributed the rise to immunity gaps among unvaccinated children, including migrants, and high population mobility due to Melaka’s status as a tourist destination. The supplementary vaccination aims to close these gaps and prevent future outbreaks.

The announcement followed the Healthy Lungs Operation event, which also marked the enforcement of the Control of Smoking Products for Public Health Act 2024.

State Health Department director Dr Ruzita Mustaffa was present. – Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings